Your browser doesn't support javascript.
loading
Impact of COVID-19 pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey (COVID-CNSMDT Study).
Price, Stephen John; Joannides, Alexis; Plaha, Puneet; Afshari, Fardad Taghizadeh; Albanese, Erminia; Barua, Neil U; Chan, Huan Wee; Critchley, Giles; Flannery, Thomas; Fountain, Daniel M; Mathew, Ryan K; Piper, Rory J; Poon, Michael Tc; Rajaraman, Chittoor; Rominiyi, Ola; Smith, Stuart; Solomou, Georgios; Solth, Anna; Surash, Surash; Wykes, Victoria; Watts, Colin; Bulbeck, Helen; Hutchinson, Peter; Jenkinson, Michael D.
Afiliação
  • Price SJ; Neurosurgery Division, Department of Clinical Neurosciences, Cambridge University, Cambridge, UK sjp58@cam.ac.uk.
  • Joannides A; Neurosurgery Division, Department of Clinical Neurosciences, Cambridge University, Cambridge, UK.
  • Plaha P; Department of Neurosurgery, John Radcliffe Hospital, Oxford, UK.
  • Afshari FT; Department of Neurosurgery, University Hospitals Coventry and Warwickshire National Health Service Trust, Coventry, UK.
  • Albanese E; Department of Neurosurgery, University Hospitals of North Midlands National Health Service Trust, Stoke-on-Trent, Staffordshire, UK.
  • Barua NU; Department of Neurosurgery, North Bristol National Health Service Trust, Bristol, UK.
  • Chan HW; Department of Neurosurgery, University Hospital Southampton National Health Service Foundation Trust, Southampton, UK.
  • Critchley G; Department of Neurosurgery, Brighton and Sussex University Hospitals National Health Service Trust, Brighton, UK.
  • Flannery T; Department of Neurosurgery, Royal Victoria Hospital, Belfast, Northern Ireland, UK.
  • Fountain DM; Manchester Centre for Clinical Neurosciences, Salford Royal National Health Service Foundation Trust, Salford, UK.
  • Mathew RK; Department of Neurosurgery, Leeds General Infirmary, Leeds, UK.
  • Piper RJ; Department of Neurosurgery, John Radcliffe Hospital, Oxford, UK.
  • Poon MT; Usher Institute, The University of Edinburgh, Edinburgh, UK.
  • Rajaraman C; Department of Neurosurgery, Hull Royal Infirmary, Hull, Kingston upon Hull, UK.
  • Rominiyi O; Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield, UK.
  • Smith S; Department of Neurosurgery, Queen's Medical Centre, Nottingham, UK.
  • Solomou G; Department of Neurosurgery, University Hospitals Coventry and Warwickshire National Health Service Trust, Coventry, UK.
  • Solth A; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Surash S; Department of Neurosurgery, Ninewells Hospital, Dundee, UK.
  • Wykes V; Department of Neurosurgery, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
  • Watts C; Department of Neurosurgery, Queen Elizabeth Hospital, Birmingham, UK.
  • Bulbeck H; Institute of Cancer and Genomic Studies, University of Birmingham, Birmingham, UK.
  • Hutchinson P; Brainstrust, Cowes, Isle of Wight, UK.
  • Jenkinson MD; Neurosurgery Division, Department of Clinical Neurosciences, Cambridge University, Cambridge, UK.
BMJ Open ; 10(8): e040898, 2020 08 16.
Article em En | MEDLINE | ID: mdl-32801210
OBJECTIVES: Pressures on healthcare systems due to COVID-19 has impacted patients without COVID-19 with surgery disproportionally affected. This study aims to understand the impact on the initial management of patients with brain tumours by measuring changes to normal multidisciplinary team (MDT) decision making. DESIGN: A prospective survey performed in UK neurosurgical units performed from 23 March 2020 until 24 April 2020. SETTING: Regional neurosurgical units outside London (as the pandemic was more advanced at time of study). PARTICIPANTS: Representatives from all units were invited to collect data on new patients discussed at their MDT meetings during the study period. Each unit decided if management decision for each patient had changed due to COVID-19. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome measures included number of patients where the decision to undergo surgery changed compared with standard management usually offered by that MDT. Secondary outcome measures included changes in surgical extent, numbers referred to MDT, number of patients denied surgery not receiving any treatment and reasons for any variation across the UK. RESULTS: 18 units (75%) provided information from 80 MDT meetings that discussed 1221 patients. 10.7% of patients had their management changed-the majority (68%) did not undergo surgery and more than half of this group not undergoing surgery had no active treatment. There was marked variation across the UK (0%-28% change in management). Units that did not change management could maintain capacity with dedicated oncology lists. Low volume units were less affected. CONCLUSION: COVID-19 has had an impact on patients requiring surgery for malignant brain tumours, with patients receiving different treatments-most commonly not receiving surgery or any treatment at all. The variations show dedicated cancer operating lists may mitigate these pressures. STUDY REGISTRATION: This study was registered with the Royal College of Surgeons of England's COVID-19 Research Group (https://www.rcseng.ac.uk/coronavirus/rcs-covid-research-group/).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Equipe de Assistência ao Paciente / Pneumonia Viral / Neoplasias Encefálicas / Infecções por Coronavirus / Tomada de Decisão Clínica Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Equipe de Assistência ao Paciente / Pneumonia Viral / Neoplasias Encefálicas / Infecções por Coronavirus / Tomada de Decisão Clínica Idioma: En Ano de publicação: 2020 Tipo de documento: Article